CEL Catalyst China Israel Fund


The Fund is a US$150 million dedicated private equity fund that supports innovative Israeli companies in capital and long term growth, along with development initiatives in the Greater China market. The Fund achieved its final closing on 31st December 2015.

Catalyst is a top performing Israeli based private equity multi-fund firm. Since 1999, the Catalyst team has established track record by managing three funds. With over US$200 million committed capital under management, Catalyst supports capital and long-term growth of innovative Israeli middle-market companies in global markets. The partners enjoy a global and multidisciplinary background, wide-reaching operational, financial and sector expertise, significant business networks and vast transactional experience in global capital markets and cross-border M&A.

Investment Strategy

The Fund invests in mid-to-late stage Israeli or Israeli-related companies, especially those with proven innovation and global growth strategy or vision. These include expansion plans into the emerging markets with a strategic focus on the Greater China market, or companies which offer products or business solutions that have a significant potential in Greater China.

The Fund focuses on sectors including agriculture, industrials/manufacturing, healthcare, water treatment, energy, technology, media and telecommunications.

The Fund aims to become a majority or significant minority shareholder in the portfolio companies. Leveraging its resources and experience, the Fund seeks to provide its portfolio companies with various value-added support in the areas including overall strategy, operation, finance, risk management, marketing and human resources to achieve its potential

Lamina Technologies

Lamina produces submicron and PVD-coated carbide inserts used in turning and milling machining processes. The company specialises in Multi-Mat™ tools – providing one universal cutting tool for processing different materials, including stainless steel, cast iron and high temperature alloys. Processes are widely used in manufacturing, aerospace, defence, automotive, abrasive and machine tools and other industries



Xjet is a world leader in 3D metal additive manufacturing, using an industry-standard patended nano technology Established in Rehovot, XJet has 66 employees, boasts 50 multidisciplinary R&D specialists and has filed more than 50 registered and pending patents.



The company specializes in R&D for semiconductor chips focusing on the satellite and quasi-satellite market, while producing its own silicon-based chip for phased array technology. SatixFy is a Hong Kong-listed company with R&D teams based in Israel and UK. As of August 2016, the company has 70 employees in Rehovot and Manof, Israel, with over 30 employees in Farnborough, UK



Taboola is a content recommendation company headquartered in the United States, providing over 360 billion referrals per month for over 1 billion independent visitors

The USA has the largest amount of desktop internet users in the world. 


Eloxx Pharmaceuticals

Founded in 2013, Eloxx Pharmaceuticals is a biopharmaceutical company committed to treating patients suffering from rare and ultra-rare genetic diseases caused by premature termination codons nonsense mutation. The Company is focused on the discovery, development and commercialization of compounds for the treatment of genetic diseases, such as Cystic Fibrosis and Cystinosis.


Raziel Therapeutics

Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug for the treatment of local fat reduction, developing a drug that targets obesity and related indications.


Lutris Pharmaceuticals

Lutris Pharmaceuticals develops drugs to improve anti-cancer therapy effectiveness. The company develops the topical B-Raf inhibitor LUT014, a proprietary small molecule that allows administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects.

Lutris Pharma was established in 2015 and is based in Tel Aviv-yafo, Israel.


Arbe Robotics

Arbe is a provider of next-generation 4D Imaging Radar Chipset Solution, enabling high-resolution sensing for ADAS and autonomous vehicles. Arbe’s technology produces detailed images, separates, identifies, and tracks objects in high resolution in both azimuth and elevation in a long range and a wide field of view, and complemented by AI-based post-processing and SLAM (simultaneous localization and mapping).  


Everbright Investment Team

  • Shengyan Fan

    Managing Partner, CEL Catalyst China Israel Fund / Managing Director, M&A Department

    Ms. Fan Shengyan is the Managing Director of the Merger & Acquisition Department, China Everbright Limited (CEL). She is responsible for CEL's private equity investment funds that invest in overseas market. Ms. Fan has 18 years’ experience in direct investment, capital raising and investment banking serving corporate clients in Greater China region as well as multinationals. Prior to joining CEL, Ms. Fan has held various positions with increasing responsibility at multinational investment banks including Lehman Brothers, Fox-Pitt, Kelton, ABN AMRO and Macquarie Group.

    Ms. Fan holds a BA and a BS from Tsinghua University and an MA from the University of Oxford. She acted as Committee Member of M&A Financing and Cross-board M&A Committee and Deputy Director in M&A Fund Committee of The China Mergers & Acquisitions Association (CMAA).

  • John Chan

    Managing Partner, CEL Catalyst China Israel Fund / Managing Director, M&A Department

    Mr. Chan is Managing Director of the Merger & Acquisition Department of CEL and is responsible for developing the principal investment portfolio and strategic initiatives for CEL. Mr. Chan is also Managing Partner of CEL Catalyst China Israel Fund and serves on the Investment Committee and Board of Directors of the General Partner. Mr. Chan previously had over 18 years of experience working with regional and international financial institutions and investment banks. He joined CEL in 2010. Mr. Chan holds MA and BA from University of Cambridge in Economics.

Catalyst Investment Team

  • Yair Shamir

    Managing Partner

    Yair Shamir is the Chairman Emeritus and Founding Partner of Catalyst Funds. In March 2013 Yair Shamir was nominated to become the Minister of Agriculture of the State of Israel. He was the Chairman of the Israel National Roads Company. He served as the Chairman of IAI (Israel Aerospace Industries) from July 2005 to July 2011. From 2005-2007, Mr. Shamir was the Chairman of Shamir Optical Industry. From 2004-2005, Mr. Shamir served as the Chairman of El Al, Israeli Airlines and lead the privatization process of the firm. From 1997- 2006, Mr. Shamir served as the CEO and Chairman of VCON Telecommunications. From 1994 to 1995, he served as CEO of Elite Food Industries. From 1988 to 1993, he served as Executive VP and General Manager of Scitex Corporation. Mr. Shamir holds a B.Sc. Electronics Engineering from the Technion, Israel Institute of Technology.

  • Edouard Cukierman

    Managing Partner

    Edouard Cukierman is the founder and Managing Partner of Catalyst Funds. He is the Chairman of Cukierman & Co Investment House, est. in 1993 & realized more than €4 billion of corporate finance transactions. He is also the founder of Go4Europe annual conference. He serves as Chairman of BOS; European Committee "High-Tech Industry Association" in Israel. He is also a board member of Lamina Technologies, Dorimedia, Harmon.ie., "Alliance Israelite Universelle en Israel", and Sar-El (Association that brings volunteers from all parts of the world to the IDF in Israel).

  • Boaz Harel

    Senior Partner

    Over 18 years PE sector experience
    Served as Chairman of Orex Radiography & led the exit to Kodak
    Founder of Mashik Research & Systems for Business Development Ltd., a consulting firm consisting of 70 management consultants and industrial engineers
    Served on the boards of BOS and Mediagate – Catalyst I portfolio companies

CEL Catalyst China Israel Fund

Tel (852) 2905 0860 / (852) 2905 0863
Fax (852) 2529 0177
Email Shengyan.Fan@everbright.com
Address 40/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong